PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P29
Within normal range
vs 2Y Ago
-3.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-43.48%
20247.86%
202312.71%
2022-36.91%
2021-42.25%
2020-48.38%
2019-45.37%
20180.00%